Shifting treatment paradigm in management of Chronic Lymphocytic Leukemia - 9 Oct 2020

Part 1 - Welcome and Introduction - Dr. Neelam Varma, Chandigarh
Part 2 - Current Status of CLL Treatment Globally - Dr. Hari Menon, Bengaluru
Part 3 - Highlights of CLL management in Indian context - Dr Sanjeev, Lucknow
Part 4- Real world experience with Acalabrutinib in management Treatment naïve CLL- Dr. John M Pagel
Part 5 - Clinical World Experience with Acalabrutinib in management of R/R CLL - Prof. Paolo Ghia
Part 6 - Panel Discussion - Dr Chezian Subhash, Chennai
Part 7 - Take-home message & Vote of Thanks - Dr. S H Advani, Mumbai & Dr. Dharma Choudhary, Delhi